Lataa...
A prospective assessment of the inter-laboratory variability of biochemical markers of fibrosis (FibroTest) and activity (ActiTest) in patients with chronic liver disease
BACKGROUND: Biochemical markers for liver fibrosis (FibroTest) and necroinflammatory features (ActiTest) are an alternative to liver biopsy in patients with chronic hepatitis C. Our aim was to assess the inter-laboratory variability of these tests, and their 6 components (γ-glutamyl transpeptidase,...
Tallennettuna:
Päätekijät: | , , , , , , , , , , , , , , |
---|---|
Aineistotyyppi: | Artigo |
Kieli: | Inglês |
Julkaistu: |
BioMed Central
2002
|
Aiheet: | |
Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC149429/ https://ncbi.nlm.nih.gov/pubmed/12537583 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1476-5926-1-3 |
Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|